EUVIMEDEUVIMED entdecken
Crossref

Structural Optimizations on the Scaffold of 7 H ‐Pyrrolo[2,3‐ d ]Pyrimidine to Develop Potent iNOS Inhibitors With Improved Antiarthritis Activity In Vivo

Wenchu Wang, Tingsheng Qin, Xianjing Feng, Mengyang Xu, Zhen Ling, Xin Xie, Min Zhang, Yanqin Huang, Jiayuan Luo, Sisi Cao, Xiaoyang Yue iD, Jie Zhang und 2 weitere

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Wenchu Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Key Laboratory of Micro-Nanoscale Bioanalysis and Drug Screening, Education De…. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type II, Pyrimidines, Pyrroles, Arthritis, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: This study was supported by the financial support from the Natural Science Foundation of Guangxi Province (2023GXNSFAA026343 and 2022GXNSFBA035470), the Nation….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inducible nitric oxide synthase (iNOS) is an attractive target to develop drugs for the treatment of rheumatoid arthritis (RA), whose overexpression leads to the release of abundant NO. In this study, a series of compounds were designed and synthesized bearing the scaffold of 7 H ‐pyrrolo[2,3‐ d ]pyrimidine to improve CLogP values and in vivo anti‐inflammatory activity via molecular hybridization, whose derivatives in a previous study demonstrated good inhibition toward NO production but high CLogP values and weak potency in vivo. Among them, N3b effectively suppressed NO production in a concentration‐dependent manner (IC 50 = 4.66 ± 0.19 μM) in LPS‐induced RAW264.7 cells. Mechanically, N3b mildly inhibited the protein expression of iNOS (IC 50 = 13.60 ± 0.39 μM), without remarkable influence on the mRNA levels of iNOS or other classical pro‐inflammatory cytokines including IL‐1β, IL‐6, and TNF‐α at the high concentration of 30 µM. With favorable drug‐likeness, N3b significantly alleviated paw edema at the dose of 30 mg/kg in the acute inflammation model and mitigated paw swelling and joint damage at a dosage of 10 mg/kg in the chronic arthritis model. Furthermore, N3b did not cause any obvious weight loss and pathological changes of important organs in treated mice, indicating that N3b is a potent candidate iNOS inhibitor for the treatment of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide Synthase Type IIPyrimidinesPyrrolesArthritis, ExperimentalArthritis, RheumatoidEnzyme InhibitorsAntirheumatic AgentsAnti-Inflammatory AgentsAnimalsMiceRAW 264.7 CellsStructure-Activity RelationshipDose-Response Relationship, DrugMaleMolecular StructureLipopolysaccharidesNitric OxideCytokines

Stichwörter der Autor:innen

7H‐pyrrolo[2,3‐d]pyrimidineNOiNOSinhibitorsrheumatoid arthritis

Substanzen

Nitric Oxide Synthase Type IIPyrimidinesPyrrolesEnzyme InhibitorsAntirheumatic AgentsLipopolysaccharidesNos2 protein, mouseNitric OxideAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Key Laboratory of Micro-Nanoscale Bioanalysis and Drug Screening, Education Department of Guangxi Zhuang Autonomous Region, Pharmaceutical College,…
  • Key Laboratory of Basic Research on Regional Diseases, College of Basic Medical Science, Guangxi Medical University, Guangxi, China.
  • School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China.

ORCID-Profile: Xiaoyang Yue, Linhong He

Förderung

  • This study was supported by the financial support from the Natural Science Foundation of Guangxi Province (2023GXNSFAA026343 and 2022GXNSFBA035470), the Nation…

Zitieren

APA

Wang, W., Qin, T., Feng, X., Xu, M., Ling, Z., Xie, X., Zhang, M., Huang, Y., Luo, J., Cao, S., Yue, X., Zhang, J., Deng, F., & He, L. (2025). Structural Optimizations on the Scaffold of 7 H ‐Pyrrolo[2,3‐ d ]Pyrimidine to Develop Potent iNOS Inhibitors With Improved Antiarthritis Activity In Vivo. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70038

Vancouver

Wang W, Qin T, Feng X, Xu M, Ling Z, Xie X, et al. Structural Optimizations on the Scaffold of 7 H ‐Pyrrolo[2,3‐ d ]Pyrimidine to Develop Potent iNOS Inhibitors With Improved Antiarthritis Activity In Vivo. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70038

BibTeX
@article{Wang2025,
  author = {Wang, Wenchu and Qin, Tingsheng and Feng, Xianjing and Xu, Mengyang and Ling, Zhen and Xie, Xin and Zhang, Min and Huang, Yanqin and Luo, Jiayuan and Cao, Sisi and Yue, Xiaoyang and Zhang, Jie and Deng, Fengyuan and He, Linhong},
  title = {Structural Optimizations on the Scaffold of 7 H ‐Pyrrolo[2,3‐ d ]Pyrimidine to Develop Potent iNOS Inhibitors With Improved Antiarthritis Activity In Vivo},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70038}
}
Kostenlos starten →